Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

INTRODUCTION: The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) were assessed in patients who were chronically infected with hepatitis C virus (HCV) genotype 2. METHODS: A total of 126 patients with chr...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Infect Dis Ther
المؤلفون الرئيسيون: Tada, Toshifumi, Kumada, Takashi, Okushin, Hiroaki, Tani, Joji, Takaguchi, Koichi, Tsutsui, Akemi, Toyoda, Hidenori, Yasuda, Satoshi, Dohmen, Kazufumi, Hiraoka, Atsushi, Michitaka, Kojiro, Nouso, Kazuhiro, Kariyama, Kazuya, Kim, Soo Ryang, Kim, Soo Ki, Fujioka, Shinichi, Mikami, Shigeru, Watanabe, Yuto, Tamai, Tsutomu, Atsukawa, Masanori, Itokawa, Norio, Tanaka, Hironori, Tsuji, Kunihiko, Ishikawa, Toru, Imai, Michitaka, Itobayashi, Ei, Shibata, Hiroshi, Shimada, Noritomo
التنسيق: Artigo
اللغة:Inglês
منشور في: Springer Healthcare 2020
الموضوعات:
Original Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954884/
https://ncbi.nlm.nih.gov/pubmed/33141401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00364-9
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة